Gemita 200 MG Injection contains Gemcitabine 200mg, a nucleoside analog chemotherapy agent widely used across multiple tumor types including pancreatic, lung, bladder, and breast cancers.

How It Works: Gemcitabine is incorporated into replicating DNA, inhibiting DNA polymerase and ribonucleotide reductase, and causing masked chain termination — preventing cancer cells from completing DNA synthesis.

Common Uses: Pancreatic cancer (first-line), non-small cell lung cancer (with cisplatin/carboplatin), bladder cancer (GemCis regimen), and metastatic breast cancer after anthracycline therapy.

Administration: Administered by IV infusion over 30 minutes in a clinical setting, typically weekly in 3-week or 4-week cycles. Dose based on body surface area.

Storage: Store at room temperature below 30°C. Reconstituted solution is stable for limited time. Do not refrigerate the reconstituted solution.

Disclaimer: This product requires a valid prescription and must be administered by a licensed medical professional. This information is for educational purposes only.